Published in Case Rep Urol on December 20, 2012
Antibodies as Mediators of Brain Pathology. Trends Immunol (2015) 0.77
An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: A case report and literature review. BMC Cancer (2016) 0.75
Bilateral Vocal Cord Paralysis and Cervicolumbar Radiculopathy as the Presenting Paraneoplastic Manifestations of Small Cell Lung Cancer: A Case Report and Literature Review. Case Rep Otolaryngol (2016) 0.75
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain (2001) 5.04
Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology (1998) 2.08
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Risk factors for bladder cancer: challenges of conducting a literature search using PubMed. Perspect Health Inf Manag (2011) 1.44
Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol (2011) 1.26
Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology (1992) 1.21
Which antibody and which cancer in which paraneoplastic syndromes? Pract Neurol (2010) 1.13
Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma. Neurology (2002) 1.04
A rare case of anti-Hu paraneoplastic neurologic syndrome in association with cervical cancer. Compr Ther (2008) 0.88
Enzyme linked immunosorbent assay using recombinant HuD-autoantigen for serodiagnosis of paraneoplastic neurological syndromes. Acta Neurol Scand (2001) 0.85
Intravenous urography for diagnosing synchronous upper-tract tumours in patients with newly diagnosed bladder carcinoma can be restricted to patients with high-risk superficial disease. Clin Radiol (2007) 0.81
The role of transarterial embolization in the treatment of renal cell carcinoma. BJU Int (2003) 1.77
One year's clinical experience with unenhanced spiral computed tomography for the assessment of acute loin pain suggestive of renal colic. BJU Int (2000) 1.62
Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study. Br J Urol (1994) 1.11
Incidence of testicular microlithiasis. Urology (1992) 1.11
Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. Eur Urol (1993) 0.91
Sonographic appearance of testicular microlithiasis. Eur Urol (1993) 0.80
The effect of sildenafil citrate administration on selected physiological parameters of exercising Thoroughbred horses. Equine Vet J Suppl (2010) 0.77
Serum neopterin as a parameter for monitoring the course of renal cell carcinoma during interferon-gamma therapy. Clin Immunol Immunopathol (1994) 0.76
Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. Urology (1994) 0.75
Penile refracture. BJU Int (2000) 0.75
The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer. Br J Urol (1998) 0.75
[Systemic therapy of OAT (oligoasthenoteratozoospermia) syndrome with pentoxifylline]. Gynakol Geburtshilfliche Rundsch (1993) 0.75
Oral pentoxifylline in therapy-resistant idiopathic OAT syndrome. Arch Androl (1994) 0.75